$YBCN
Yong Bai Chao New Retail Corp

2023 Q1 Form 10-Q Financial Statement

#000147793223003918 Filed on May 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $25.00K $8.970K $20.21K
YoY Change 23.7% -0.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $25.00K $8.970K $20.21K
YoY Change 23.73% -0.22% 236.75%
Operating Profit -$25.00K -$20.21K
YoY Change 23.73% 236.75%
Interest Expense $0.00 $0.00 $6.250K
YoY Change -100.0% -100.0% -16.69%
% of Operating Profit
Other Income/Expense, Net $0.00 -$6.250K
YoY Change -100.0% -113.34%
Pretax Income -$25.00K -$8.970K -$26.46K
YoY Change -5.5% -122.92% -164.74%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$25.00K -$8.970K -$26.46K
YoY Change -5.5% -122.92% -164.74%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$195.20
COMMON SHARES
Basic Shares Outstanding 189.1M shares
Diluted Shares Outstanding 189.1M shares 135.6M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.15K $1.970K $2.720K
YoY Change 861.4% -18.93%
Accrued Expenses $0.00 $258.6K
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $250.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.64K $44.64K $544.9K
YoY Change -87.22% -91.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $69.64K $44.64K $544.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $69.64K $44.64K $544.9K
YoY Change -87.22% -91.39%
SHAREHOLDERS EQUITY
Retained Earnings -$3.639M -$3.614M -$3.544M
YoY Change 2.67% 2.74%
Common Stock $195.5K $195.5K $141.9K
YoY Change 37.73% 37.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $0.00
YoY Change -100.0%
Treasury Stock Shares 375.0K shares
Shareholders Equity -$69.64K -$44.64K -$544.9K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$25.00K -$8.970K -$26.46K
YoY Change -5.5% -122.92% -164.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00 $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities $0.00 0.000 $0.00
Cash From Investing Activities
Cash From Financing Activities 0.000
Net Change In Cash $0.00 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
42674 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189495068 shares
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001284454
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189495068 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189120068 shares
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2009Q3 ybcn Penalty Fees
PenaltyFees
0.1 pure
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-206764
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Yong Bai Chao New Retail Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3626387
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
No. 3205-3209, South Building, No. 3
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Intelligence Industrial Park
CY2023Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
No.39 Hulan West Road, Baoshan District
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CN
CY2023Q1 dei City Area Code
CityAreaCode
86
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
135-8568-1065
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
189120068 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
43497 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189120068 shares
CY2023Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20205 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
6250 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6250 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26455 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26455 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
189120068 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
135569068 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189120068 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135569068 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-44642 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-69642 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-518488 usd
CY2022Q1 ybcn Correction Of An Error
CorrectionOfAnError
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26455 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-544943 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-25000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-26455 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24177 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
284 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
0 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
6250 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
823 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
19921 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q3 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
50000000 shares
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3638691 usd
CY2023Q1 ybcn Working Capital Deficit
WorkingCapitalDeficit
69642 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
6250 usd
CY2022Q3 us-gaap Convertible Debt
ConvertibleDebt
150000 usd
CY2022Q3 us-gaap Convertible Debt
ConvertibleDebt
100000 usd
CY2022Q3 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
516508 usd
CY2023Q1 ybcn Recent Accounting Pronouncementsdisclosuretextblock
RecentAccountingPronouncementsdisclosuretextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management does not believe there would have been a material effect on the accompanying unaudited condensed financial statements had any recently issued, but not yet effective, accounting standards been adopted in the current period.</p>
CY2009Q3 ybcn Investor Relations Agreement Description
InvestorRelationsAgreementDescription
Pursuant to such agreement, the Company agreed to pay a fee of $1,000 per month for a period of six months beginning on August 1, 2009 and ending January 1, 2010. The Company should have issued 75,000 shares within 7 days of signing the agreement. Any payments over 45 days would be subject to a penalty fee of 10% per week.
CY2010Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
75000 shares
CY2022Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2010Q1 ybcn Additional Shares Issued
AdditionalSharesIssued
75000 shares
CY2009Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd

Files In Submission

Name View Source Status
0001477932-23-003918-index-headers.html Edgar Link pending
0001477932-23-003918-index.html Edgar Link pending
0001477932-23-003918.txt Edgar Link pending
0001477932-23-003918-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ybcn-20230331.xsd Edgar Link pending
ybcn_10q.htm Edgar Link pending
ybcn_ex311.htm Edgar Link pending
ybcn_ex312.htm Edgar Link pending
ybcn_ex321.htm Edgar Link pending
ybcn_ex322.htm Edgar Link pending
ybcn-20230331_cal.xml Edgar Link unprocessable
ybcn-20230331_pre.xml Edgar Link unprocessable
ybcn-20230331_lab.xml Edgar Link unprocessable
ybcn-20230331_def.xml Edgar Link unprocessable
ybcn_10q_htm.xml Edgar Link completed